Brief: United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
30/10/2024 10:57
Oct 30 (Reuters) - United Therapeutics Corp UTHR.O :
* UNITED THERAPEUTICS CORPORATION REPORTS THIRD QUARTER 2024
FINANCIAL RESULTS
* UNITED THERAPEUTICS CORP - Q3 NET INCOME, PER DILUTED
SHARE
$6.39
Source text: ID:nBw1ZKRCYa
Further company coverage: UTHR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug